NeuroOne Earns Notice of Allowance for Key U.S. Patent

NeuroOne Medical Technologies Corporation has received a Notice of Allowance for a key U.S. patent related to its neural probe technology.

Titled, “Methods for Making Probe Devices and Related Devices,” the new patent is strategic in nature and covers novel methods of creating neural probe devices, including specific steps for arranging probe components and the deposition of electrode contact material.

A Notice of Allowance is issued by the U.S. Patent and Trademark Office after examining a patent application and determining a patent should be granted. NeuroOne expects to be issued the patent in the coming months.

In addition to this allowed patent application, NeuroOne’s portfolio includes 17 issued and pending patents in the United States and internationally, covering a wide variety of thin-film electrode technologies. Among these include both neural and spinal cord electrodes with unique structures to optimize the functionality and minimize the profile of those electrodes.

“One of the key aspects with this patent relates to the novel method of electrode material deposition for all of our electrodes that are both commercially available and in development,” NeuroOne CEO Dave Rosa said. “We believe that this new patent will better protect and advance our entire technology platform as we continue to develop and introduce new applications.”

NeuroOne Medical Technologies Corporation is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, monitoring, ablation, drug delivery and stimulation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence.